Literature DB >> 2844575

Activation of multiple hemopoietic growth factor genes in Abelson virus-transformed myeloid cells.

R K Humphries1, S Abraham, G Krystal, P Lansdorp, F Lemoine, C J Eaves.   

Abstract

We have recently shown that Abelson murine leukemia (A-MuLV) virus can transform cells in large mixed colonies to give tumorigenic myeloid cell lines capable of autonomous growth in vitro. Initial studies revealed that granulocyte-macrophage colony-stimulating factor (GM-CSF) production was consistently activated in these cells. Using a sensitive S1 RNA mapping technique and additional bioassays, we have now obtained evidence of expression of other hemopoietic growth factor genes. Uniformly 32P-labeled, single-stranded DNA probes (greater than 4 x 10(8) cpm/micrograms) were generated for interleukin 3 (IL-3) and GM-CSF using pTZ based vectors. IL-3 mRNA was detected in four of four cloned transformants (from two different infections) at approximately 1% of the level seen in pokeweed mitogen (PWM)-stimulated spleen cells. GM-CSF mRNA was detected in the two clones that showed the highest IL-3 mRNA levels. Medium conditioned by these cells was able to stimulate IL-3-dependent 32D cells, and IL-3- and GM-CSF-dependent B6SUtA cells, and also supported the growth of a variety of single and multilineage colonies in assays of mouse marrow cells even in the presence of neutralizing antibodies to GM-CSF. Rearrangements of the IL-3 and GM-CSF genes were not apparent by Southern blot analysis. Additional bioassays revealed the presence of two other growth factors: IL-6 (hybridoma growth factor or Ifn-beta 2) assayed on B13.29 cells, a factor-dependent murine B-cell hybridoma; and a new pre-B-cell stimulatory factor different from any of the above. Elucidation of the mechanism underlying this phenomenon may provide important insights into the regulation of hemopoietic growth factor gene expression and the role such genes play in human leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844575

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

1.  Hyperexpression of interleukin-7 is not necessary or sufficient for transformation of a pre-B lymphoid cell line.

Authors:  J C Young; M L Gishizky; O N Witte
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

2.  Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A.

Authors:  C M Williams; J W Coleman
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

3.  Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice.

Authors:  A Oshiba; E Hamelmann; K Takeda; K L Bradley; J E Loader; G L Larsen; E W Gelfand
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

4.  Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene.

Authors:  S W Chung; P M Wong; H Durkin; Y S Wu; J Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

5.  Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine.

Authors:  R W Overell; L Clark; D Lynch; R Jerzy; A Schmierer; K E Weisser; A E Namen; R G Goodwin
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

6.  Ligand stimulation of transfected and endogenous growth factor receptors enhances cytokine production by mast cells.

Authors:  A D Keegan; J H Pierce; J Artrip; M Plaut; W E Paul
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

7.  bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

Authors:  A G Elefanty; I K Hariharan; S Cory
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

8.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines.

Authors:  P R Burd; H W Rogers; J R Gordon; C A Martin; S Jayaraman; S D Wilson; A M Dvorak; S J Galli; M E Dorf
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.